Greenleaf Trust Abbott Laboratories Transaction History

Greenleaf Trust

$11.2 Billion
Q3 2024

A detailed history of Greenleaf Trust transactions in Abbott Laboratories stock. As of the latest transaction made, Greenleaf Trust holds 98,436 shares of ABT stock, worth $11.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

98,436

Previous 97,126 1.35%

Holding current value

$11.4 Million

Previous $10.1 Million 11.2%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$100.07 - $118.13 $131,091 - $154,750	1,310 Added 1.35%	98,436 $11.2 Million
Q2 2024 Jul 22, 2024	SELL	$100.73 - $112.44 $199,243 - $222,406	-1,978 Reduced 2.0%	97,126 $10.1 Million
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $23,875 - $26,369	218 Added 0.22%	99,104 $11.3 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $91,272 - $111,724	-1,012 Reduced 1.01%	98,886 $10.9 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $326,330 - $391,541	-3,416 Reduced 3.31%	99,898 $9.68 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $773,385 - $861,713	7,674 Added 8.02%	103,314 $11.3 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $368,649 - $433,922	3,806 Added 4.14%	95,640 $9.68 Million
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $2.63 Million - $3.09 Million	-27,666 Reduced 23.15%	91,834 $10.1 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $3.99 Million - $4.61 Million	41,192 Added 52.6%	119,500 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $2.52 Million - $3.04 Million	24,643 Added 45.92%	78,308 $8.51 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $57,010 - $69,520	500 Added 0.94%	53,665 $6.35 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $125,350 - $153,484	-1,085 Reduced 2.0%	53,165 $7.48 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $152,474 - $168,681	1,307 Added 2.47%	54,250 $6.41 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $580,258 - $683,047	5,485 Added 11.56%	52,943 $6.14 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $474,107 - $558,569	4,356 Added 10.11%	47,458 $5.69 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $108,990 - $118,767	1,038 Added 2.47%	43,102 $4.72 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $344,291 - $418,116	3,757 Added 9.81%	42,064 $4.58 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $256,432 - $328,202	3,349 Added 9.58%	38,307 $3.5 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $42,843 - $62,648	682 Added 1.99%	34,958 $2.76 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $40,668 - $45,273	518 Added 1.53%	34,276 $2.98 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $64,980 - $70,459	794 Added 2.41%	33,758 $2.83 Million
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $106,259 - $123,930	1,458 Added 4.63%	32,964 $2.77 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $22,647 - $27,380	342 Added 1.1%	31,506 $2.52 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $239,687 - $271,531	3,656 Added 13.29%	31,164 $2.25 Million
Q3 2018 Oct 29, 2018	BUY	$60.81 - $73.36 $120,768 - $145,692	1,986 Added 7.78%	27,508 $2.02 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $180,712 - $199,452	3,139 Added 14.02%	25,522 $1.56 Million
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $62,290 - $70,427	1,107 Added 5.2%	22,383 $1.34 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $116,378 - $124,594	2,168 Added 11.35%	21,276 $1.21 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $918,330 - $1.02 Million	19,108	19,108 $1.02 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account